Analyst Ranking
Top 19%
#916 out of 4875 analysts
Average Return
+5.66%
Win Rate
53%20 out of 38
Risk vs Reward
Poor
Good

Chase Knickerbocker's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Eton Pharmaceuticals IncETON
+352.53%$3.75$16.97
2024-05-06 -
2025-05-05
Buy
Eton Pharmaceuticals IncETON
+139.86%$7.00$16.79
2024-10-04 -
2025-05-09
Buy
Eton Pharmaceuticals IncETON
+99.41%$8.42$16.79
2024-10-28 -
2025-05-09
Buy
Delcath Systems IncDCTH
+77.30%$8.37$14.84
2024-06-28 -
2025-05-09
Buy
Indivior PLCINDV
+48.53%$7.46$11.08
2024-10-11 -
2025-05-09
Buy

Chase Knickerbocker Analyst Color

Get additional color on Chase Knickerbocker's coverage of popular stocks

Chase Knickerbocker's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Eton Pharmaceuticals IncETON
5Buy$26.00+54.85%Maintains
2 months ago
Xeris Biopharma Holdings IncXERS
1Buy$6.50+29.74%Maintains
2 months ago
Mediwound LtdMDWD
1Buy$39.00+122.54%Initiates Coverage On
2 months ago
Ironwood Pharmaceuticals IncIRWD
4Buy$8.00+1,028.35%Maintains
4 months ago
Delcath Systems IncDCTH
2Buy$21.00+41.51%Maintains
4 months ago
Koru Medical Systems IncKRMD
2Buy$6.00+90.48%Maintains
4 months ago
Scpharmaceuticals IncSCPH
2Buy$12.00+391.80%Maintains
6 months ago
Polypid LtdPYPD
1Buy$10.00+261.01%Initiates Coverage On
6 months ago
Indivior PLCINDV
3Buy$16.00+44.40%Maintains
7 months ago
Harrow IncHROW
3Buy$65.00+166.39%Maintains
7 months ago
Grace Therapeutics IncGRCE
2Buy$8.00+194.12%Maintains
8 months ago
Fennec Pharmaceuticals IncFENC
4Buy$15.00+152.10%Maintains
9 months ago
Mimedx Group IncMDXG
2Buy$12.00+70.21%Maintains
9 months ago
Codere Online Luxembourg SaCDRO
1Buy$10.00+22.10%Initiates Coverage On
10 months ago
Avadel Pharmaceuticals PLCAVDL
2Buy$23.00N/AMaintains
a year ago
Xtant Medical Holdings IncXTNT
2Buy$1.20N/AMaintains
2 years ago
Phathom Pharmaceuticals IncPHAT
1Buy$21.00N/AInitiates Coverage On
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.